Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has provided an update.
WuXi AppTec plans to introduce a 2026 H Share Award and Trust Scheme, subject to shareholder approval at the 2025 annual general meeting, to grant equity awards to selected participants over a ten-year period funded by internal resources. The scheme aims to modernize the company’s remuneration structure, better align management and employee incentives with shareholder interests, and support long-term growth by tying vesting to individual performance indicators, while connected executives and their associates will abstain from voting on the proposal.
The board has resolved to seek authorization for itself and a designated delegate to handle all matters related to the implementation and administration of the 2026 scheme, ensuring operational flexibility in granting and managing award shares. By focusing on attracting, motivating and retaining experienced personnel and leadership through equity participation, the company is reinforcing its commitment to prudent management and sustained expansion of the group’s business.
The most recent analyst rating on (HK:2359) stock is a Hold with a HK$124.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a China-incorporated joint stock company whose H shares are listed on the Hong Kong Stock Exchange under stock code 2359. The group operates in the biopharmaceutical and life-sciences services industry, providing research, development and related services, and uses equity-based incentives to attract and retain key talent and align management with shareholders.
Average Trading Volume: 4,883,675
Technical Sentiment Signal: Buy
Current Market Cap: HK$303.7B
For a thorough assessment of 2359 stock, go to TipRanks’ Stock Analysis page.

